01—History
Long-Term Debt History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2019–FY2025. Drag across the bars to change the range.
- $39.44B
02—Ledger
Long-Term Debt, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $39.44B | +28.7% | 10-K | |
| FY2024 | $30.65B | +18.4% | 10-K | |
| FY2023 | $25.88B | −13.7% | 10-K | |
| FY2022 | $29.98B | −8.1% | 10-K | |
| FY2021 | $32.63B | +23.2% | 10-K | |
| FY2019 | $26.49B | −4.3% | 10-K | |
| FY2018 | $27.68B | −9.8% | 10-K | |
| FY2017 | $30.68B | +138.6% | 10-K | |
| FY2016 | $12.86B | −15.0% | 10-K | |
| FY2014 | $15.12B | +13.5% | 10-K | |
| FY2013 | $13.33B | +16.0% | 10-K | |
| FY2012 | $11.49B | +25.5% | 10-K | |
| FY2011 | $9.16B | +11.3% | 10-K | |
| FY2010 | $8.22B | +1.3% | 10-K | |
| FY2008 | $8.12B | — | 10-K |
03—Questions
What is long-term debt?
Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.
What is JOHNSON & JOHNSON's current long-term debt?
JOHNSON & JOHNSON (JNJ) annual long-term debt for 2025 was $39.44B, a 28.67% increase from 2024. JOHNSON & JOHNSON long-term debt for the quarter ending June 28, 2026 was $37.34B.
What was JOHNSON & JOHNSON's long-term debt in 2024?
JOHNSON & JOHNSON annual long-term debt for 2024 was $30.65B, a 18.43% increase from 2023.
What was JOHNSON & JOHNSON's long-term debt in 2023?
JOHNSON & JOHNSON annual long-term debt for 2023 was $25.88B, a 13.69% decline from 2022.
What is JOHNSON & JOHNSON's 4-year long-term debt CAGR?
JOHNSON & JOHNSON long-term debt grew at a compound annual growth rate (CAGR) of 4.85% from FY2021 to FY2025, going from $32.63B to $39.44B over 4 years.
- Company
- JOHNSON & JOHNSON
- Ticker
- JNJ
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations